U.S. market Closed. Opens in 1 day 6 hours 59 minutes

HRMY | Harmony Biosciences Holdings, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for HRMY we got that it has strong fundamentals where Valuation is considered to be slightly undervalued, Profitability is very wealthy, Growth is exceptionally good and Health is strong.

Valuation (69%)

Company Industry
P/E Ratio (TTM) 15.90 -15.27
PEG Ratio (TTM) 1.85 -4.35
P/S Ratio (TTM) 2.87 45.97
P/B Ratio (TTM) 3.27 28.96
P/FCF Ratio (TTM) 8.88 -2.59
Price to 5YR AVG Earnings Ratio 70.21 -5.56
Price to 5YR AVG FCF Ratio 85.70 -12.33

Profitability (80%)

Company Industry
ROA (TTM) 13.21% -19.06%
ROE (TTM) 23.16% 15.70%
Net Profit Margin (TTM) 17.98% -813.88%
ROIC 5YR AVG 24.65% 3.12%

Growth (85%)

4QTR AVG 3YR AVG 5YR AVG
EPS 63.53% 7.69% 81.08%
Revenue 4.08% 885.27% 546.42%
Net Income 60.29% -20.74% 66.66%
Cash Flow 16.10% 1,134.45% 700.36%

Health (65%)

Company Industry
Current Ratio (TTM) 3.24 5.56
Quick Ratio (TTM) 3.20 5.34
D/E Ratio (TTM) 0.31 0.95
Interest Coverage (TTM) 6.10 -6.44
Piotroski F-Score 6 5
Altman Z-Score 5.40 12.45
LTL to 5YR AVG FCF 7.83 0.11
Shares Outstanding Growth 5YR AVG 4.63% 37.46%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙